Espinosa de los Monteros-Sánchez AL, Valdivia-López J, Mendoza-Zubieta V, Mercado-Atri M, Gómez-Pérez F, Vergara-López A, Romero-Zazueta A, Hernández-García I, Reza-Albarrán A, Portocarrero-Ortiz L, Cortinas-López L, Rangel-Sánchez G, González-Villaseñor G, Martínez-Sibaja C, Orozco R

Idioma: Español
Referencias bibliográficas: 39
Paginas: 3-12
Archivo PDF: 148.06 Kb.

FRAGMENTO

INTRODUCCIÓN

El síndrome de Cushing (SC) se presenta como consecuencia de la exposición prolongada a glucocorticoides. El síndrome de Cushing exógeno, resultado de la administración de estos compuestos, es la causa más común. El SC endógeno es menos frecuente y se debe a un exceso en la producción de cortisol, como resultado de un tumor productor de ACTH, el cual puede ser de origen hipofisiario (Enfermedad de Cushing, 70% de los casos), o ectópico (15%); o bien debido a una lesión suprarrenal (adenoma, carcinoma o hiperplasia).

REFERENCIAS (EN ESTE ARTÍCULO)

1. Nieman L, Ilias I. Evaluation and treatment of Cushing’s syndrome. Am J Med 2005; 118: 1340-6.

2. Raff H, Findling J. A physiologic approach to diagnosis of Cushing syndrome. Ann Intern Med 2003; 138: 980-91.

3. Yanovski J, Gordon C, Chrousos G, Nieman L. Corticotropin realizing hormone stimulation following low dose dexamethasone administration. A new test to distinguish Cushing’s syndrome from pseudo-Cushing states. JAMA 1993; 269: 2232-8.

4. Papanicolaou D, Yanovski J, Cutler G, Chrousos G, Nieman L. A single midnight serum cortisol measurement distinguishes Cushing’s syndrome from pseudo-Cushing status. J Clin Endocrinol Metab 1998; 83: 1163-7.

5. Newell-Price J, Trainer P, Perry L et al. A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing’s syndrome. Clin Endocrinol 1995;43: 545-50.

6. Putignano P, Toja P, Dubini A, Giraldi F, Corsello A, Cavagnini F. Midnight salivary cortisol versus urinary free and midnight serum cortisol as screening tests for Cushing’s syndrome. J Clin Endocrinol Metab 2003; 88: 4153.

7. Findling J, Raff H. Screening and diagnosis of Cushing’s syndrome. Endocrinol Metab Clin N Am 2005; 34: 385-402.

8. Wu T, Machacelo D, Jiang N, Hao P. Urinary free cortisol and cortisone determined by high performance liquid chromatography in the diagnosis of Cushing’s syndrome. J Clin Endocrinol Metab 1997; 82: 151-5.

9. Word P, Barth J, Freedman D, Perry L, Sheridan B. Evidence for the low dose dexamethasone suppression test to screen for Cushing’s syndrome, recommendations for a protocol for biochemistry laboratories. Ann Clin Biochem 1997; 34: 222-9.

10. Lindsay J, Nieman L. Differential diagnosis and imaging in Cushing’s syndrome. Endocrinol Metab Clin N Am 2005; 34: 403-21.

11. Nieman L, Oldfield E, Wesley R, Chrousos G, Loriaux L, Cutler G. A simplified morning ovine corticotropin releasing hormone stimulation test for the differential diagnosis of adrenocorticotropin-dependent Cushing’s syndrome. J Clin Endocrinol Metab 1993; 77: 1308-12.

12. Flack M, Oldfiel E, Cutler G, Zweing M, Malley J, Chrousos G et al. Urine free cortisol in the high dose dexamethasone suppression test for the differential diagnosis of the Cushing’s syndrome. Ann Intern Med 1992; 116: 211-17.

13. Dichek H, Nieman L, Oldfield E, Pass H, Malley J, Cutler G. A comparison of the standard high dose dexamethasone suppression test for the differential diagnosis of adrenocorticotropin dependent Cushing’s syndrome. J Clin Endocrinol Metab 1994; 78: 418-22.

14. van den Bogaert D, de Herder W, de Jong F, Biemond P, van der Lely, Lamberts S. The continuous 7-hour intravenous dexamethasone suppression test in the differential diagnosis of ACTH-dependent Cushing’s syndrome. Clin Endocrinol 1999; 51: 193-8.

15. Corrigan D, Schaaf M, Whaley R, Czarwinski C, Earl J. Selective venous sampling to differentiate ectopic ACTH secretion from pituitary Cushing’s syndrome. N Engl J Med 1977; 296: 861-2.

16. Machado M, de Sa S, Domenico S, Villares M, Puglia P, Albergaria M et al. The role of desmopressin in bilateral and simultaneous inferior petrosal sinus sampling for differential diagnosis of ACTH-dependent Cushing’s syndrome. Clinical Endocrinology 2007; 66: 136.

17. Reimondo G, Pia A, Allasino B, Tassonet F, Bovio S, Borretta G et al. Screening of Cushing’s syndrome in adult patients with newly diagnosed diabetes mellitus. Clin Endocrinol 2007; 67: 225-29.

18. Terzolo M, Pia A, Alin A, Osella G, Reimondo G, Bovio S et al. Adrenal incidentaloma: a new cause of the metabolic syndrome? J Clin Endocrinol Metab 2002; 87: 998-1003.

19. Hernández I, Espinosa de los Monteros AL, Mendoza V, Cheng S, Molina M, Sosa E et al. Ectopic ACTH secreting syndrome: a single center experience report with a high prevalence of occult tumor. Arc Med Res 2006; 37: 976-80.

20. Ilias I, Torpy D, Pacak K, Mullen N, Wesley R, Nieman L. Cushing’s syndrome due to ectopic corticotropin secretion: Twenty years experience at the National Institutes of Health. J Clin Edocrinol Metab 2005; 90: 4955-62.

21. Isidori A, Kaltsas G, Pozza C, Frajese V, Newell-Price J, Reznek R. The ectopic Adrenocorticotropin Syndrome: clinical features, diagnosis, management, and long-term follow-up. J Clin Endocrinol Metab 2006; 91: 371-7.

22. Christopoulos S, Bourdeau I, Lacroix A. Clinical and subclinical ACTH-Independent macronodular adrenal hyperplasia and aberrant hormone receptors. Horm Res 2005; 64: 119-31.

23. Doppman J, Chang R, Oldfield E et al. The hypoplastic inferior petrosal sinus: a potential source of false-negative results in petrosal sampling for Cushing’s disease. J Clin Endocrinol Metab 1999; 84: 533-40.

24. McCance D, Gordon D, Fannin T, Hadden D, Kennedy L, Sheridan B et al. Assessment of endocrine function after trans-sphenoidal surgery for Cushing’s disease. Clin Endocrinol 1993; 38: 79-86.

25. Trainer P, Lawrie H, Verhelst J, Howlett T, Lowe D, Grossman A et al. Trans-sphenoidal resection in Cushing´s disease: undetectable serum cortisol as the definition of successful treatment. Clin Endocrinol 1993; 38: 73-8.

26. Esposito F, Dusick J, Cohan P, Moftakhar P, McArthur D, Wang C et al. Early morning cortisol levels as a predictor of remission after trans-sphenoidal surgery for Cushing´s disease. J Clin Endocrinol Metab 2006; 91: 7-13.

27. Jenkins P, Trainer P, Plowman P, Shand W, Grossman A, Wass J, Besser G. The long term outcome after adrenalectomy and prophylactic pituitary radiotherapy in adrenocorticotropin dependent Cushing´s syndrome. J Clin Endocrinol Metab 1994; 79: 165-71.

28. Gil A, Herrera M, Díaz A, Ríos J, Pantoja J. Nelson´s syndrome after bilateral adrenalectomy for Cushing´s disease. Surgery 2007; 141: 47.

29. Boscaro M, Sonino N, Scarda A, Barzon L, Fallo F, Sartori M et al. Anticoagulant prophylaxis markedly reduces thromboembolic complications in Cushing´s syndrome. J Clin Endocrinol Metab 2002; 87: 3662-6.

30. Keil M, Batista D, Constantine A. Early identification of Cushing’s Syndrome in children. The National Institutes of Health, Bethesda, MD.

31. Laffferty A, Chroussos G. Pituitary tumors in children and adolescents. J Clin Endocrinol Metab 1999; 84: 4317-23.

32. Mindermann T, Wilson C. Pediatric pituitary adenomas. Neurosurgery 1995; 36: 259-69.

33. Ward O, Mott M, Smith J et al. Cushing´s syndrome and bronchial carcinoid tumor. Arch Dis Child 1984; 59: 375-7.

34. Norman T, Havnen J, Mjolnerod O. Cushing´s syndrome in an infant associated with neuroblastoma in two ectopic adrenal glands. J Pediatr Surg 1971; 6: 169-75.

35. Newell-Price J, Bertagna X, Grossman A, Nieman L. Cushing´s syndrome. Lancet 2006; 367: 1605-17.

36. Magiakou M, Mastorakos G, Oldfeld E et al. Cushing´s syndrome in children and adolescents: Presentation, diagnosis and therapy. N Engl J Med 1994; 331: 629-36.

37. Acosta F, Coyote N, Medina P. Carcinoma corticosuprarrenal en niños. Experiencia del Hospital Infantil de México Federico Gómez,1986 a 2006. Tesis de Pediatría. UNAM.

38. Arnaldi G, Angeli A, Atkinson B, Bertagna X et al. Diagnosis and complications of Cushing´s syndrome: a consensus statement. J Clin Endoc Metab 2003; 88: 5593-5602.

39. Gafni R, Papanicolaou D, Niemann L. Night time salivary cortisol measurement as a simple, non invasive outpatient screening test for Cushing´s syndrome in children an adolescents. J Pediatr 2000; 137: 30-5.